SEC Form 4 · accession 0001221375-26-000002
Bioventus Inc. · BVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susan M Stalnecker
Director
Period of report
Jun 2, 2026
Accepted (ET)
Jun 4, 2026 · 4:47 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001665988
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Jun 2, 2026 | M | 32,282 | $0.00 | A | 138,239 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Jun 2, 2026 | M | 32,282 | D | — | — | Class A Common Stock | 32,282 | 0 | D |
| Restricted Stock UnitsF1,F3 | — | Jun 3, 2026 | A | 25,146 | A | — | — | Class A Common Stock | 25,146 | 25,146 | D |
Explanation of responses
- F1Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
- F2The RSUs vested on June 2, 2026.
- F3The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.